Anal Fissure Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Anal Fissure Therapeutics Market is estimated to grow at a CAGR of 8% during the forecast period 2022-2028.

An anal fissure is a linear rupture of the lining of the mucous membrane of the distal anal canal below the dentate line. Common symptoms of anal fissures include severe pain during and after a bowel movement that lasts minutes to hours. These cracks are mainly due to trauma to the lining of the anus and are mainly caused by hard and dry bowel movements, but are sometimes observed as a cause of diarrhea and loose stools. Severe anal pain can cause spasm of the anal sphincter, which reduces blood flow to the site of injury, ultimately prolonging the wound healing process. The next bowel movement causes more anal cramps, pain, and reduced blood flow to the wound, and the cycle continues. Treatment aims to break this cycle by relaxing the anal sphincter to promote fissure healing. 87% of people with chronic anal fissures are between the ages of 20 and 60. Anterior fissures are more likely to occur in women (25%) than men (8%), but anal fissures affect men and women equally.

Market Segments

By Type

• Surgery
• Medication

By Route of Administration

• Topical
• Oral

Key Players

Abbott Laboratories, GlaxoSmithKline Plc, Valeant Pharmaceuticals, Eisai Co. Ltd. Taro Pharmaceutical Industries Ltd. Cook, Pfizer Inc. AstraZeneca, Bayer AG, Allergan Inc., Novasep, Geri-care Pharmaceuticals, healthy Life Pharma, Taj Pharmaceuticals, Troikaa Pharmaceuticals, PurduePharma, SRS Pharmaceuticals, Cigna, and others.

Scope of the Report

The research study analyzes the global Anal Fissure Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Anal Fissure Therapeutics Market Report

1. What was the Anal Fissure Therapeutics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Anal Fissure Therapeutics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Anal Fissure Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.